Berkshire Hathaway bought seven new stocks in its first quarter under Greg Abel. That is the headline. It is also the wrong frame.
The more useful number is $397 billion. That is how much cash and short-term Treasuries Berkshire sat on at the end of March. It is roughly the GDP of Italy. And for all the excitement about new positions in Delta and Macy's, Abel spent $16 billion buying stocks while pulling $24.1 billion out. He was a net seller.
The portfolio shrunk from about 40 positions to 26. He exited entire holdings - including UnitedHealth, which he sold in full, wiping out roughly 5 million shares worth about $1.4 billion. UnitedHealth stock fell nearly 6% in one session on the news. That kind of reaction shows how much attention these moves get. It also shows how easily the market reads Berkshire's footnotes as prophecy.
Here is the thing people miss. Berkshire is not running a fund anymore. It is running a war chest.
Abel didn't inherit a portfolio that needs refreshing. He inherited one that was already over-concentrated. Apple alone was 22% of the equity portfolio at quarter end. American Express was 17.4%. Coca-Cola, the rest of the bank holdings, a few more - the top five positions ate most of the table. There was nowhere to add without either doubling down on names he already loved or buying something that barely moves the needle.
So he did something Buffett rarely did in his final years: he sat. He bought Delta, which he'd held before and knows well - 39.8 million shares worth $2.6 billion, making it the 14th-largest holding. He picked up Macy's, a small position by Berkshire standards. He increased his Alphabet stake by 224%, which sounds aggressive until you realize you can increase a small stake by 224% and it is still small.
None of these are category bets. They are opportunistic buys in companies with known business models that happened to look cheap. Delta when airline valuations are depressed. Macy's when retail gets punished broadly. Alphabet after whatever overhang was pressing on it. This is not a new philosophy. It is the old one, practiced with more patience.
The $397 billion is what changes everything. Buffett built that pile through years of selling when valuations stretched. Abel is keeping it. Operating profits rose in Q1, driven by insurance, which is the engine that funds all of this. But the real story is the optionality: nearly $400 billion in dry powder means Berkshire can act when the market breaks. It also means Berkshire is telling you, loudly, that nothing else looks like a good deal right now.
That is uncomfortable for shareholders who want action. But it is the right call. Most investors at this scale can't do what Berkshire can: wait. Mutual funds have redemption risk. Pension funds have payout schedules. Berkshire has neither. The cash earns 4–5% in T-bills while the market works through whatever cycle we're in. That is real money on real dollars.
I suspect Abel will deploy more aggressively when valuations soften - or if a recession creates the kind of dislocation Buffett always hunted. But the lesson from Q1 is not which of the seven new buys will turn out best. It is that the best buy right now might be the one he hasn't made yet.
If you own Berkshire, the question isn't whether Abel is buying the right stocks. It is whether you trust a strategy that says: wait for the fat pitch. The 40-to-26 compression shows he is not lazy. He is selective. And at this cash level, selectivity is the only thing that matters.
The test for Abel's first year won't come from what he bought in Q1. It will come from whether he deploys that $397 billion when the opportunity is real - not when the market demands he do something, and not when his own board grows impatient. The clock starts now.